1:12 PM
 | 
May 08, 2017
 |  BC Extra  |  Financial News

Aadi raises $23M series A round

Aadi Bioscience Inc. (Pacific Palisades, Calif.) raised $23 million in a series A led by Hermed Capital. Also participating were Celgene Corp. (NASDAQ:CELG), Vivo Capital, Decheng Capital, Helsinn Investment Fund and Star Summit Ventures.

Aadi gained rights to its sole asset,

Read the full 200 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >